Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Dosing and administration Medical professionals typically administer ipamorelin via subcutaneous injections, with standard dosages ranging from 200 to 300 mcg per day
Mechanism of Action Comparison IGF-1 LR3 Reduced IGFBP-1, -2, -3 binding affinity Extended circulating half-life (~20-30 hours) Sustained IGF-1 receptor activation Full receptor binding affinity maintained IGF-1 DES Reduced IGFBP binding via truncation Short half-life (~20-30 minutes) Rapid, acute receptor activation Enhanced receptor binding potency reported Research Applications Comparison The choice between IGF-1 LR3 and IGF-1 DES depends on the specific temporal requirements of your research
Ipamorelin is a pentapeptide that binds the ghrelin receptor (GHSR-1a) and prompts the pituitary gland to release a pulse of endogenous growth hormone, making it a secretagogue, not a fat-loss compound per se
The future of longevity medicine increasingly emphasizes interventions that support cellular health and prevent age-related decline rather than merely managing disease after it develops
8 FDA Drug Approval Package: Tepezza (teprotumumab-trbw)
This is because IGF-1 production decreases throughout ones lifespan
US$ 25.61
US$ 24.31
US$ 29.68
US$ 28.76
US$ 20.47
